| | Call Details | Spectranetics Earnings Conference Call (Q1 2008) Wed,
Apr 23, 2008, 10:00 am Eastern
| | About Spectranetics
(NasdaqGM:SPNC) |
| | The Spectranetics Corporation develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system using its excimer laser technology. The companys Excimer laser technology delivers relatively cool ultraviolet energy to remove arterial blockages, including plaque, calcium, and thrombus. It offers a range of proprietary laser devices designed for indications, including peripheral laser atherectomy in the upper and lower leg; and coronary laser atherectomy. The companys peripheral laser atherectomy products include TURBO Elite Catheters for peripheral laser atherectomy; TURBO-Booster for the TURBO elite laser catheters facilitating directed laser ablation of blockages in the main arteries at or above the knee; and Quick-Cross Support Catheter that supports catheters for use in the cardiovascular system to support and assist standard guidewires to facilitate initial crossing of the blockage. Its coronary laser atherectomy products comprise disposable catheters consisting of Rapid Exchange Catheter, Over-The-Wire Catheter, POINT 9 Catheter, and Quick-Cross Support Catheter. The Spectranetics Corporation also offers devices for the removal of infected, defective, or abandoned pacemaker and implantable cardiac defibrillators leads. The companys CVX-300 excimer laser unit includes Spectranetics Laser Sheath, a laser-assisted lead removal device; and Lead Locking Device, a mechanical device that assists in the removal of faulty leads by providing traction on the inner aspect of the leads, which are constructed of wire coils covered by insulating material. It operates in the United States, Canada, Mexico, South America, the Pacific Rim, and Australia. The Spectranetics Corporation was founded in 1984 and is based in Colorado Springs, Colorado. |
| More
Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Insider
|
Financials
|
Analyst Ratings |
|